InterCure Reports Record FY 2021 Revenue Of $89M, Q4 Adjusted EBITDA Spikes 140% YoY
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR), which is doing business as Canndoc, has announced its estimated financial and operating results for the fourth quarter and year ended December 31, 2021.
Benzinga ·
Benzinga
